Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Mastocytosis × Injections × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 58 Breast Neoplasms 44 Myelodysplastic Syndromes 25 Neoplasms 23 Advanced Solid Tumor 22 Carcinoma, Non-Small-Cell Lung 21 Advanced Solid Tumors 20 Prostatic Neoplasms 19 Stomach Neoplasms 16 Recurrence 16 Neoplasm Metastasis 15 Multiple Myeloma 14 Carcinoma, Hepatocellular 14 Leukemia, Myelomonocytic, Chronic 13 Pancreatic Neoplasms 12 Lung Neoplasms 12 Solid Tumor 11 Ovarian Neoplasms 11 Uterine Cervical Neoplasms 10 Melanoma 10 Lymphoma, Large B-Cell, Diffuse 10 Sarcoma 9 Myeloproliferative Disorders 8 Colorectal Neoplasms 8 Small Cell Lung Carcinoma 7 Lymphoma, B-Cell 7 Esophageal Neoplasms 7 Biliary Tract Neoplasms 7 Lymphoma, Non-Hodgkin 6 Cholangiocarcinoma 6

Interventions

masitinib 4 Imatinib Mesylate 2 midostaurin 1 fludarabine phosphate 1 fludarabine 1 Whole-Body Irradiation 1 Transplantation 1 Tacrolimus 1 Stem Cell Transplantation 1 Single-Cell Gene Expression Analysis 1 Radiotherapy 1 Peripheral Blood Stem Cell Transplantation 1 Mycophenolic Acid 1 Injections 1 Dasatinib 1 Cyclophosphamide 1 Cromolyn Sodium 1 Cladribine 1 Busulfan 1 AK002 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01333293 2016-01-18

XOLMA

University of Zurich

Phase 2/3 Completed

Mastocytosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡